National Generic Pharmaceuticals – Project Revive

NHS England is soliciting proposals for National Generic Pharmaceuticals – Project Revive under solicitation number CM/PHG/26/5767. This framework agreement is designed to provide pharmaceutical services across multiple UK regions, including London, the North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, South East, and South West. The estimated total value of the contract is 6,864,264 GBP excluding VAT, or 8,237,117 GBP including VAT. The procurement is noted as being particularly suitable for small and medium-sized enterprises. The initial period of performance is estimated from 1 April 2027 to 31 January 2029, covering a duration of 22 months across the DCE/DSW, DLS/DNE, and DLN/DNW regions. At the discretion of the authority, the contract may be extended for up to 26 months, allowing for a maximum total contract length of 48 months with a potential end date of 31 March 2031. Award decisions will be based on a combination of criteria where price is not the only factor. The deadline for tender submissions is 30 November 2026 at 1:00pm, with an enquiry deadline of 23 November 2026.